The ROE as of September 2024 (TTM) for vTv Therapeutics Inc. (VTVT) is 638.41%

According to vTv Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is 638.41%. This represents a change of -17867.11% compared to the average of -3.59% of the last 4 quarters.

vTv Therapeutics Inc. (VTVT) Historical ROE (quarterly & annually)

How has VTVT ROE performed in the past?

The mean historical ROE of vTv Therapeutics Inc. over the last ten years is 63.40%. The current 638.41% ROE has changed 906.90% with respect to the historical average. Over the past ten years (40 quarters), VTVT's ROE was at its highest in in the March 2022 quarter at 116.45%. The ROE was at its lowest in in the June 2024 quarter at -31.44%.

vTv Therapeutics Inc. (VTVT) ROE by Quarter and Year

Discovering the peaks and valleys of vTv Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

vTv Therapeutics Inc. (VTVT) Average ROE

How has VTVT ROE performed in the past?

The current ROE of vTv Therapeutics Inc. (VTVT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

vTv Therapeutics Inc. (VTVT) ROE vs. Peers

How is VTVT’s ROE compared to its peers?

vTv Therapeutics Inc.’s ROE is greater than Zura Bio Limited (-35.45%), greater than Apexigen, Inc. (-606.56%), greater than Phio Pharmaceuticals Corp. (-142.68%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Immix Biopharma, Inc. (-86.48%), greater than Sigilon Therapeutics, Inc. (-81.98%), greater than NovaBay Pharmaceuticals, Inc. (-431.13%), greater than InMed Pharmaceuticals Inc. (-53.37%), greater than GeoVax Labs, Inc. (-852.58%), greater than Generation Bio Co. (-92.86%), greater than Kronos Bio, Inc. (-68.82%), greater than Erasca, Inc. (-131.94%), greater than C4 Therapeutics, Inc. (-44.60%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Allarity Therapeutics, Inc. (-704.78%), greater than NeuroBo Pharmaceuticals, Inc. (-154.04%), greater than Hillstream BioPharma, Inc. (-47249.59%), greater than Virax Biolabs Group Limited (-115.10%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%), greater than Pyxis Oncology, Inc. (-38.34%), greater than Altamira Therapeutics Ltd. (-233.96%), greater than Elevation Oncology, Inc. (-57.97%),

Build a custom stock screener for vTv Therapeutics Inc. (VTVT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like vTv Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

vTv Therapeutics Inc. (VTVT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like vTv Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.